Study of GS-4321 for chronic hepatitis delta
Part of Digestive system, Infections clinical trials.
This trial tests a new drug, GS-4321, for people with chronic hepatitis delta, a serious liver infection. It aims to see if the drug is safe and effective, and compares results in healthy volunteers and those with the virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have chronic hepatitis delta for at least 6 months.
- You need to be on a standard hepatitis B treatment like entecavir, TAF, or TDF.
- Your liver must be either not scarred or have compensated cirrhosis (no severe liver failure).
- Your hepatitis delta virus level must be above 500 IU/mL at screening.
- Your ALT liver enzyme level must be higher than normal but not extremely high.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, Libevitug, for people with chronic hepatitis D (HDV). It aims to see if the drug can help control the virus and improve liver health.
This trial tests a new drug called Hepalatide for people with chronic hepatitis D (a liver infection). You must already have hepatitis B and be on a stable antiviral for it. The study checks if Hepalatide can safely lower HDV levels.
This trial tests a new drug called GST-HG141 for people with chronic hepatitis B whose virus is still active despite taking standard antiviral pills. It aims to see if the new drug can better control the virus.
This study tests an experimental antibody (GIGA-2339) given as an infusion to people with chronic Hepatitis B. It aims to see if the drug is safe and how the body processes it, possibly helping to control the virus.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This study tests a new antibody treatment (VIR-3434) for chronic hepatitis B. It aims to see if the antibody can help your immune system control the virus, potentially allowing you to stop your current antiviral medication later.
Hear when a new Chronic Hepatitis Delta trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.